SOLICITATION NOTICE
R -- PS-OC Bioresource Core Facility (PBCF) - Draft Statement of Work
- Notice Date
- 7/2/2010
- Notice Type
- Presolicitation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions-Treatment and Support Branch, Bldg 244, Room 112, Frederick, Maryland, 21702
- ZIP Code
- 21702
- Solicitation Number
- N02-CO-07036-02
- Point of Contact
- Mandie S. White, Phone: 3012284217, Timothy V Crilley, Phone: 301/228-4224
- E-Mail Address
-
whitems@mail.nih.gov, tcrilley@mail.nih.gov
(whitems@mail.nih.gov, tcrilley@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Draft Statement of Work Title: PS-OC Bioresource Core Facility (PBCF) Pre-solicitation Notice General Information: This is not a Request for Proposal (RFP). The National Cancer Institute (NCI), National Institutes of Health (NIH) intends to negotiate with the American Type Culture Collection (ATCC) on a sole source basis for a five (5) year period (inclusive of options). This is a new requirement. Purpose: The purpose of this project is to provide a central bioresource core facility to all members of the PS-OC Network. This PS-OC Bioresource Core Facility (PBCF) shall serve as a biorepository and a distributor of biospecimens to the PS-OC Network investigators. This contract shall supply cancer cell lines, primary cells, DNA, RNA and protein isolates from such cells and reagents needed for the propagation of the cell lines. The PC-OC Network is in need of a consistent and reliable supply of well characterized cancer cells that will be distributed on an ongoing basis to 25 to 50 laboratories throughout the United States. While breast, colorectal, glioma and leukemia will initially be investigated, additional cancers will be of interest and thus a large number of different cell lines will be required. The NCI's requirement can only be met by American Type Culture Collection (ATCC); they possess unique capabilities, expertise and a sizeable network. ATCC is recognized as a world leader with a history in standard biological reference materials management and the common source in scientific community for cell line stocks, with a large cell collection, well established internal procedures and well organized global distribution mechanisms. ATCC has an in-house cell culture collection that encompasses in excess of 3,600 normal cell lines and 950 cancer cell lines, which include but not limited to breast, colorectal, leukemia, glioma, liver, pancreas, prostate, ovary, lung, melanoma, and non-Hodgkin lymphoma. With their in-house collection capacity, ATCC will have the ability to supply the required materials to the PS-OC investigators in an expeditious manner. ATCC has the bioresource materials in-house as well as the internal structure for storage and distribution of the materials to investigators. Based on the size and capacity of ATCC's cell collection, as well as their successful track record with cell distribution, ATCC is the only known organization that can fulfill this requirement without expending substantial costs/efforts that would be required in establishing or acquiring a network of normal and cancer cell lines of this magnitude. Authority: 41 U.S.C. 253(c)(1), as set forth in FAR 6.302-1(a)(2)(ii). This notice of intent is not a request for competitive proposals. No solicitation document exists. If there are any responsible contractors who have proven experience and meet the capabilities cited to perform the requirement, they may submit tailored capability statements that document experience, capabilities and qualifications which will be considered by the NCI. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described within this synopsis and the attached draft Statement of Work. Your tailored capability statement can be submitted electronically (via e-mail) to C. Timothy Crilley at tcrilley@mail.nih.gov and Mandie S. White at whitems@mail.nih.gov in Adobe Portable Document Format (PDF) or by mail at the below addresses. If submitting the capability statement via e-mail, the subject line must specify N02-CO-07036-02. Facsimile responses will not be accepted. All information received within fifteen (15) calendar days after date of publication of this synopsis will be considered by the Government. Capability statements received after the due date and time will not be considered. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. Please reference solicitation number N02-CO-07036-02 on all correspondence. If no responses are received, NCI will proceed with a sole source award. 1. Points of Contact: C. Timothy Crilley, Contracting Officer tcrilley@mail.nih.gov Phone: 301-228-4224 (No collect calls will be accepted) AND/OR Mandie S. White, Contract Specialist whitems@mail.nih.gov Phone: 301-228-4217 (No collect calls will be accepted) Contracting Office Address: If hand-delivered or delivery service C. Timothy Crilley, Contracting Officer Treatment and Support Branch Office of Acquisitions, NCI National Cancer Institute Building 244, Room 112 Frederick, MD 21702-1201 If using U.S. Postal Service, delete Building 244 Room 112 and replace with P.O. Box B, 244 Miller Drive, Rm 112 NOTE: Ft. Detrick is a secured military base. All visitors to the base must go through a security screening process before gaining access to the base. It is your responsibility to ensure that sufficient time is allotted to enter Fort Detrick, locate and deliver your capability statement prior to the date and time specified for receipt. It is recommended that you contact Mandie White on 301-228-4217 or Tim Crilley on 301-228-4224 to schedule a specific date/time in order to deliver your capability statement.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/FCRF2/N02-CO-07036-02/listing.html)
- Record
- SN02195804-W 20100704/100702234645-79ed9c52153ecf1ce088cda4c7af0924 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |